<p>在过去的 7 天里，美国市场上涨了 2.8%，在过去 12 个月中上涨了 9.3%，预计年收益将增长 14%。在这样的环境下，识别财务状况良好的股票对于寻求价值和增长潜力的投资者来说变得至关重要。虽然便士股票由于其较小的规模或较新的状态常被视为小众，但当它们展现出强健的财务健康和长期前景时，仍然可以提供独特的机会。</p>
<h3>美国十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国便士股票筛选器的 748 只股票完整列表。</p>
<p>我们将查看筛选工具中一些最佳选择。</p>
<h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Blade Air Mobility, Inc. 提供美国及国际医院的空中运输和物流服务，市值为 2.3427 亿美元。</p>
<p><strong>运营：</strong> 该公司主要通过两个部门产生收入：医疗服务贡献了 1.4682 亿美元，乘客服务带来了 1.0188 亿美元。</p>
<p><strong>市值：</strong> 2.3427 亿美元</p>
<p>尽管目前处于亏损状态，Blade Air Mobility, Inc. 仍展现出韧性，2024 年净亏损为 2731 万美元，较去年 5608 万美元的亏损有所改善。该公司享有强健的财务状况，没有债务，短期资产为 1.607 亿美元，远超负债，为基于自由现金流提供了超过三年的现金流。近期的举措包括与 Skyports Infrastructure 合作的试点项目，旨在扩大纽约市的城市空中出行服务，可能增强未来的收入来源和运营效率，随着其向电动垂直起降飞机的过渡。</p>
<ul>
<li>在这里深入了解 Blade Air Mobility 的具体情况，查看我们的详细资产负债表健康报告。</li>
<li>通过访问我们的收益增长报告评估 Blade Air Mobility 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis"/></p>
<p>NasdaqCM:BLDE 财务状况分析截至 2025 年 5 月</p>
<h2>Cardlytics (NasdaqGM:CDLX)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Cardlytics, Inc. 在美国和英国运营一个广告平台，市值约为 9.6 亿美元。</p>
<p><strong>运营：</strong> 该公司的收入主要来自其 Cardlytics 平台，产生了 2.5562 亿美元，以及其 Bridg 平台，贡献了 2268 万美元。</p>
<p><strong>市值：</strong> 9.6 亿美元</p>
<p>Cardlytics, Inc. 面临挑战，仍处于亏损状态，2024 年净亏损为 1.893 亿美元，较前一年的亏损有所扩大。尽管相对价值良好，且短期资产为 1.78 亿美元，覆盖了短期和长期负债，但其 211.4% 的高净债务与股本比率引发了对财务杠杆的担忧。该公司最近修订了贷款协议，将到期日延长至 2028 年，且没有借入额外资金，保持了 6000 万美元的可用信贷。2025 年第一季度的收入指引设定在 5700 万至 6000 万美元之间，表明在运营波动中收入压力持续。</p>
<ul>
<li>解锁我们对 Cardlytics 股票分析的全面见解，查看此财务健康报告。</li>
<li>通过检查我们的增长报告了解 Cardlytics 的收益前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:CDLX 收入与支出分析截至 2025 年 5 月</p>
<h2>Douglas Elliman (NYSE:DOUG)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Douglas Elliman Inc. 在美国的房地产服务和物业技术投资领域运营，市值约为 1.6222 亿美元。</p>
<p><strong>运营：</strong> 该公司的收入主要来自美国的房地产服务和物业技术投资，总额为 10.5 亿美元。</p>
<p><strong>市值：</strong> 1.6222 亿美元</p>
<p>Douglas Elliman Inc. 的市值为 1.6222 亿美元，报告收入为 10.5 亿美元，但仍处于亏损状态，股本回报率为负（-25.61%）。尽管 2025 年第一季度收入较去年增加至 2.534 亿美元，但公司录得净亏损 599 万美元，虽然较之前的亏损有所改善，但对于关注盈利能力的投资者来说仍然令人担忧。公司的短期资产超过其短期负债，提供了一定的财务稳定性；然而，长期负债仍未被这些资产覆盖，突显出在其通过近期的货架注册申请和收益电话会议努力稳定运营的过程中潜在的风险。</p>
<ul>
<li>点击这里查看完整的分析健康报告，以深入了解 Douglas Elliman。</li>
<li>通过我们关于公司历史业绩的报告，获取 Douglas Elliman 过去趋势和表现的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 5 月 NYSE:DOUG 收入与支出明细</p>
<h2>总结</h2>
<ul>
<li>在这里探索我们美国便士股票筛选器中的 748 个名称。</li>
<li>准备好采取不同的方法了吗？寻找现金流潜力良好但交易价格低于公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>如果您想交易 Cardlytics，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

DOUG

BLDE

SRTA

<p>美国市场在过去一周上涨了 2.8%，在过去一年中上涨了 9.3%，预计年收益增长将达到 14%。在这一增长中，财务状况良好的低价股受到关注，包括 Blade Air Mobility、Cardlytics 和 Douglas Elliman，尽管面临挑战，但各自展现出独特的机会。Blade Air Mobility 的市值为 2.3427 亿美元，且没有债务；Cardlytics 的市值为 9.6 亿美元，但面临盈利问题。Douglas Elliman 的市值为 1.6222 亿美元，报告收入为 10.5 亿美元，但仍处于亏损状态。投资者被鼓励探索这些股票，以寻找潜在的价值和增长</p>

<p>Over the last 7 days, the United States market has risen 2.8%, and over the past 12 months, it is up 9.3%, with earnings forecasted to grow by 14% annually. In such a climate, identifying stocks with strong financials becomes crucial for those seeking value and growth potential. Penny stocks, though often considered niche due to their smaller size or newer status, can present unique opportunities when they demonstrate robust financial health and long-term promise.</p>
<div class="lb-trans"><p>在过去的 7 天里，美国市场上涨了 2.8%，在过去 12 个月中上涨了 9.3%，预计年收益将增长 14%。在这样的环境下，识别财务状况良好的股票对于寻求价值和增长潜力的投资者来说变得至关重要。虽然便士股票由于其较小的规模或较新的状态常被视为小众，但当它们展现出强健的财务健康和长期前景时，仍然可以提供独特的机会。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美国十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 748 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国便士股票筛选器的 748 只股票完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我们将查看筛选工具中一些最佳选择。</p>
</div><h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
<div class="lb-trans"><h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Blade Air Mobility, Inc. offers air transportation and logistics services for hospitals both in the United States and internationally, with a market cap of $234.27 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Blade Air Mobility, Inc. 提供美国及国际医院的空中运输和物流服务，市值为 2.3427 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue from two main segments: Medical services, which contributed $146.82 million, and Passenger services, which brought in $101.88 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过两个部门产生收入：医疗服务贡献了 1.4682 亿美元，乘客服务带来了 1.0188 亿美元。</p>
</div><p><strong>Market Cap:</strong> $234.27M</p>
<div class="lb-trans"><p><strong>市值：</strong> 2.3427 亿美元</p>
</div><p>Blade Air Mobility, Inc. has shown resilience despite being currently unprofitable, with a net loss of US$27.31 million for 2024, an improvement from the previous year's US$56.08 million loss. The company benefits from a robust financial position with no debt and short-term assets of US$160.7 million exceeding liabilities significantly, providing a cash runway for over three years based on free cash flow. Recent initiatives include a pilot program in partnership with Skyports Infrastructure aimed at expanding urban air mobility services in New York City, potentially enhancing future revenue streams and operational efficiencies as they transition to electric vertical aircraft operations.</p>
<div class="lb-trans"><p>尽管目前处于亏损状态，Blade Air Mobility, Inc. 仍展现出韧性，2024 年净亏损为 2731 万美元，较去年 5608 万美元的亏损有所改善。该公司享有强健的财务状况，没有债务，短期资产为 1.607 亿美元，远超负债，为基于自由现金流提供了超过三年的现金流。近期的举措包括与 Skyports Infrastructure 合作的试点项目，旨在扩大纽约市的城市空中出行服务，可能增强未来的收入来源和运营效率，随着其向电动垂直起降飞机的过渡。</p>
</div><ul>
<li>Dive into the specifics of Blade Air Mobility here with our thorough balance sheet health report.</li>
<li>Evaluate Blade Air Mobility's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 Blade Air Mobility 的具体情况，查看我们的详细资产负债表健康报告。</li>
<li>通过访问我们的收益增长报告评估 Blade Air Mobility 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis"/></p>
<p>NasdaqCM:BLDE Financial Position Analysis as at May 2025</p>
<div class="lb-trans"><p>NasdaqCM:BLDE 财务状况分析截至 2025 年 5 月</p>
</div><h2>Cardlytics (NasdaqGM:CDLX)</h2>
<div class="lb-trans"><h2>Cardlytics (NasdaqGM:CDLX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom, with a market cap of approximately $960 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Cardlytics, Inc. 在美国和英国运营一个广告平台，市值约为 9.6 亿美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Cardlytics Platform, generating $255.62 million, and its Bridg Platform, contributing $22.68 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自其 Cardlytics 平台，产生了 2.5562 亿美元，以及其 Bridg 平台，贡献了 2268 万美元。</p>
</div><p><strong>Market Cap:</strong> $96M</p>
<div class="lb-trans"><p><strong>市值：</strong> 9.6 亿美元</p>
</div><p>Cardlytics, Inc. faces challenges as it remains unprofitable with a net loss of US$189.3 million for 2024, widening from the prior year's loss. Despite trading at good relative value and having short-term assets of US$178 million covering both short- and long-term liabilities, its high net debt to equity ratio of 211.4% raises concerns about financial leverage. The company recently amended its loan facility extending maturity to 2028 without borrowing additional funds, maintaining US$60 million in available credit. Revenue guidance for Q1 2025 is set between US$57-60 million, indicating continued revenue pressures amidst operational volatility.</p>
<div class="lb-trans"><p>Cardlytics, Inc. 面临挑战，仍处于亏损状态，2024 年净亏损为 1.893 亿美元，较前一年的亏损有所扩大。尽管相对价值良好，且短期资产为 1.78 亿美元，覆盖了短期和长期负债，但其 211.4% 的高净债务与股本比率引发了对财务杠杆的担忧。该公司最近修订了贷款协议，将到期日延长至 2028 年，且没有借入额外资金，保持了 6000 万美元的可用信贷。2025 年第一季度的收入指引设定在 5700 万至 6000 万美元之间，表明在运营波动中收入压力持续。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Cardlytics stock in this financial health report.</li>
<li>Understand Cardlytics' earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 Cardlytics 股票分析的全面见解，查看此财务健康报告。</li>
<li>通过检查我们的增长报告了解 Cardlytics 的收益前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:CDLX Revenue &amp; Expenses Breakdown as at May 2025</p>
<div class="lb-trans"><p>NasdaqGM:CDLX 收入与支出分析截至 2025 年 5 月</p>
</div><h2>Douglas Elliman (NYSE:DOUG)</h2>
<div class="lb-trans"><h2>Douglas Elliman (NYSE:DOUG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Douglas Elliman Inc. operates in the real estate services and property technology investment sectors in the United States, with a market cap of approximately $162.22 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Douglas Elliman Inc. 在美国的房地产服务和物业技术投资领域运营，市值约为 1.6222 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates its revenue primarily from real estate services and property technology investments in the United States, amounting to $1.05 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入主要来自美国的房地产服务和物业技术投资，总额为 10.5 亿美元。</p>
</div><p><strong>Market Cap:</strong> $162.22M</p>
<div class="lb-trans"><p><strong>市值：</strong> 1.6222 亿美元</p>
</div><p>Douglas Elliman Inc. operates with a market cap of US$162.22 million and reported revenues of US$1.05 billion, yet remains unprofitable with a negative return on equity (-25.61%). Despite an increase in revenue to US$253.4 million for Q1 2025 from the previous year, the company recorded a net loss of US$5.99 million, an improvement from prior losses but still concerning for investors focused on profitability. The company's short-term assets exceed its short-term liabilities, providing some financial stability; however, long-term liabilities remain uncovered by these assets, highlighting potential risks amidst its ongoing efforts to stabilize operations through recent shelf registration filings and earnings calls.</p>
<div class="lb-trans"><p>Douglas Elliman Inc. 的市值为 1.6222 亿美元，报告收入为 10.5 亿美元，但仍处于亏损状态，股本回报率为负（-25.61%）。尽管 2025 年第一季度收入较去年增加至 2.534 亿美元，但公司录得净亏损 599 万美元，虽然较之前的亏损有所改善，但对于关注盈利能力的投资者来说仍然令人担忧。公司的短期资产超过其短期负债，提供了一定的财务稳定性；然而，长期负债仍未被这些资产覆盖，突显出在其通过近期的货架注册申请和收益电话会议努力稳定运营的过程中潜在的风险。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Douglas Elliman.</li>
<li>Gain insights into Douglas Elliman's past trends and performance with our report on the company's historical track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里查看完整的分析健康报告，以深入了解 Douglas Elliman。</li>
<li>通过我们关于公司历史业绩的报告，获取 Douglas Elliman 过去趋势和表现的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown"/></p>
<p>NYSE:DOUG Revenue &amp; Expenses Breakdown as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月 NYSE:DOUG 收入与支出明细</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>总结</h2>
</div><ul>
<li>Explore the 748 names from our US Penny Stocks screener here.</li>
<li>Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里探索我们美国便士股票筛选器中的 748 个名称。</li>
<li>准备好采取不同的方法了吗？寻找现金流潜力良好但交易价格低于公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>If you're looking to trade Cardlytics, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 Cardlytics，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用，无账户最低要求，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

3 只市值超过 9000 万美元的有潜力的便士股票